Skip to Content

TransGlobal Assets Inc TMSH

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

TMSH is trading at a 429% premium.
Price
$0.00
Fair Value
$3.49
Uncertainty
Extreme
1-Star Price
$2.85
5-Star Price
$6.67
Economic Moat
Xwzj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if TMSH is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.00
Bid/Ask
$0.00 / $0.00
Market Cap
$413,061.95
Volume/Avg
3.5 Mil / 49.6 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

TransGlobal Assets Inc provides customers with a wide range of high-quality CBD & THC products from its organically grown Clones, Teens and Mothers. Its self-sustaining Hemp Ranch will be vertically integrated from acres allocated, to outdoor cultivation and indoor greenhouses, to warehouses for processing farm-grown hemp into textiles, hempcrete & plastics and processing all-natural products.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Total Number of Employees

Valuation

Metric
TMSH
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
TMSH
Quick Ratio
0.00
Current Ratio
Interest Coverage
Quick Ratio
No chart available

Profitability

Metric
TMSH
Return on Assets (Normalized)
−276.71%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRYzjqxtpjMphtbnz$78.2 Bil
ZTS
Zoetis Inc Class AGqxjxwpnmWdscb$78.0 Bil
HLN
Haleon PLC ADRNtlqcrhyXpc$38.4 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRHsnkdyxTgjdp$19.1 Bil
VTRS
Viatris IncRmjlsdtSyqy$12.5 Bil
RDY
Dr Reddy's Laboratories Ltd ADRVtwgflnSyws$11.8 Bil
CTLT
Catalent IncXzpjjdwcRlwtgd$9.9 Bil
PRGO
Perrigo Co PLCXtnxvvrTkns$3.8 Bil
CURLF
Curaleaf Holdings IncNctkxcdVfg$3.5 Bil
PBH
Prestige Consumer Healthcare IncGgbgxkqcgTjvftn$3.2 Bil

Sponsor Center